mdl-100907 and Cholangitis--Sclerosing

mdl-100907 has been researched along with Cholangitis--Sclerosing* in 1 studies

Other Studies

1 other study(ies) available for mdl-100907 and Cholangitis--Sclerosing

Article	Year
Role of the serotoninergic system in the development of diseases of the intestinal and biliferous tracts. Bulletin of experimental biology and medicine, 2009, Volume: 147, Issue:5 Primary sclerosing cholangitis and nonspecific ulcerative colitis were modeled before and after serotonin and spiperone injections. Activation of the serotoninergic system prevented the development of primary sclerosing cholangitis, but promoted more severe course of nonspecific ulcerative colitis. Topics: Animals; Cholangitis, Sclerosing; Colitis, Ulcerative; Dopamine Antagonists; GABA Modulators; Myocytes, Smooth Muscle; Pentobarbital; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Spiperone; Trinitrobenzenesulfonic Acid	2009

Article

Year

Role of the serotoninergic system in the development of diseases of the intestinal and biliferous tracts.

Bulletin of experimental biology and medicine, 2009, Volume: 147, Issue:5

Primary sclerosing cholangitis and nonspecific ulcerative colitis were modeled before and after serotonin and spiperone injections. Activation of the serotoninergic system prevented the development of primary sclerosing cholangitis, but promoted more severe course of nonspecific ulcerative colitis.

Topics: Animals; Cholangitis, Sclerosing; Colitis, Ulcerative; Dopamine Antagonists; GABA Modulators; Myocytes, Smooth Muscle; Pentobarbital; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Spiperone; Trinitrobenzenesulfonic Acid

2009